You are here: Industry Insights > COVID-19

News List

Fulcrum Begins of Losmapimod Trial for Hospitalized COVID-19 Patients americanpharmaceuticalreview
July 03, 2020
Fulcrum Therapeutics has received early notification from the U.S. Food and Drug Administration (FDA) that the company may proceed with initiating a Phase 3, randomized, double-blind, placebo-controlled trial of losmapimod in higher risk ...
IgNova Files Patent Application on Antibody Against COVID-19 americanpharmaceuticalreview
July 03, 2020
IgNova has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY).
EMD Serono Initiates Trial of TLR7, 8 Inhibitor as a Potential Treatment for Symptoms of Covid-19 americanpharmaceuticalreview
July 03, 2020
EMD Serono announced the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug application (IND) for M5049 for the treatment of patients with Covid-19 pneumonia.
Virality Diagnostics Antibody Test Wins FDA EUA americanpharmaceuticalreview
July 03, 2020
The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for a rapid COVID-19 antibody test distributed by Virality Diagnostics, manufactured by Biohit (Hefei).
NeuroRx, Relief Announce Fast Track Designation for Respiratory Distress Treatment in COVID-19 americanpharmaceuticalreview
July 03, 2020
NeuroRx, in partnership with Relief Therapeutics, announced the U.S. Food and Drug Administration (FDA) awarded Fast Track Designation to NeuroRx for the investigation of RLF-100 (Aviptadil) for the treatment of acute lung injury ...
Further billions pledged to ensure equitable access to COVID-19 treatments europeanpharmaceuticalreview
July 03, 2020
The European Investment Bank (EIB), in partnership with the European Commission (EC), have pledged an additional €4.9 billion for use in the global coronavirus response funds.
Mylan gets approval to make and market remdesivir expresspharma
July 03, 2020
Jubilant, BDR and Dr Reddy's Labs have also awaiting permission from CDSCO to manufacture and market the drug in India and are still awaiting due permission.
Brazil to test Sinovac’s potential vaccine against COVID-19 in six states expresspharma
July 03, 2020
The agreement with Sinovac includes not only trials but also the transference of technology to produce the coronavirus vaccine locally.
COVID-19 Impact on Fingerprint Sensor Market - Exclusive Report by MarketsandMarkets? prnewswire
July 02, 2020
The fingerprint sensor market includes major Tier I and II players like Goodix, Fingerprint Cards, Synaptics, Apple, and Qualcomm.
FlowForma Combats COVID-19 Business Disruption and Accelerates Digital Transformation With New Collaboration Bundles prnewswire
July 02, 2020
FlowForma has launched a range of Remote Collaboration bundles to help companies rapidly digitize processes and minimize the impact of COVID-19. The company's no-code approach to business process automation provides a fast fix for 'keeping the lights on'